Table 1.
MS women (147) (age range: 45–55 ys) | ||
---|---|---|
Non-menopausal MS women (63) | Menopausal MS women (84) | |
Age (mean ± sd) years | 46.1 ± 3.1 | 52.6 ± 3.2** |
MS duration (mean ± sd) years | 15.5 ± 6.3 | 18.2 ± 8.7* |
EDSS score | 3.3 ± 1.8 | 3.4 ± 2.1 |
Age at Menopause onset (mean ± sd) years | NA | 48.5 ± 4.3 |
Follow-up post menopause (mean ± sd) years | NA | 4.2 ± 3.5 |
Use of II° line DMTs | 15 (23.8%) | 15 (17.8%)* |
*p value: <0.05; ***p value: <0.005. Chi-square and independent-samples t-tests were used to compare demographic and clinical variables between the two groups.